FUJIFILM Diosynth Biotechnologies Invests £400M in UK Bio-Mfg. Site

FUJIFILM Diosynth Biotechnologies, a CDMO for biologics, viral vaccines and viral vectors, is investing £400 million at its UK facility in Billingham, Teesside. The investment will more than double the site’s existing development and manufacturing footprint, creating the largest multi-modal Biopharmaceutical manufacturing site in the UK, and is expected to create up to 350 highly-skilled jobs. The new facilities are expected to be operational by late 2023.